Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Nuveen's price for Schroders 'too cheap', says Panmure Liberum

(Sharecast News) - Panmure Liberum said on Thursday that US investment manager Nuveen's 612p a share takeover offer for Schroders is "too cheap" and "only a touch ahead of where we might have been pitching a new target price in an independent world". Schroders shares surged nearly 30% on Thursday after it agreed to be taken over by Nuveen in £9.9bn deal. Under the terms of the acquisition, Nuveen - which is part of the Teachers Insurance and Annuity Association of America - will pay 612p per share.

The price comprises a cash consideration of 590p a share and permitted dividends of up to 22p per share. The cash consideration is a 29% premium to the closing share price on Wednesday.

Responding to the news, Panmure said it had a note ready to outline how well the company had done, how quickly management had delivered change, how much more upside there was to come as the market started to fully appreciate all that had happened in just 15 months.

"Instead Nuveen will take the spoils, offering 612p per share, only a touch ahead of where we might have been pitching a new target price in an independent world," it said.

"With the offer being recommended the Family has clearly decided to move on, but the rest of us will be poorer for it."

Panmure continued: "Who would ever have believed in Schroders being bid for? Certainly not us for most of the last three and half decades, but then after a prolonged period of share price underperformance resulting from a prolonged period of poor management and business drift, there were the first signs of a change in the attitude of the Family.

"We fear that the offer came too soon in the process of change, and another year of the kind of change seen already in 15 months might have put the share price in a different starting place."

Panmure Liberum has a 'buy' rating and 475p price target on the stock.

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.